In recent trading session, Colgate-Palmolive Co (NYSE:CL) saw 0.75 million shares changing hands at last check today with its beta currently measuring 0.37. Company’s recent per share price level of $87.94 trading at $0.14 or 0.16% at last check today assigns it a market valuation of $71.27B. That most recent trading price of CL’s stock is at a discount of -24.29% from its 52-week high price of $109.30 and is indicating a premium of 2.98% from its 52-week low price of $85.32. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 5.41 million shares which gives us an average trading volume of 5.36 million if we extend that period to 3-months.
For Colgate-Palmolive Co (CL), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 2.18. Splitting up the data highlights that, out of 17 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 5 suggested the stock as a Hold whereas 12 see the stock as a Buy. 0 analyst(s) advised it as an Underweight.
Colgate-Palmolive Co (NYSE:CL) trade information
Upright in the green today for gaining 0.16%, in the last five days CL remained trading in the red while hitting it’s week-highest on Tuesday, 06/24/25 when the stock touched $87.94 price level, adding 0.91% to its value on the day. Colgate-Palmolive Co’s shares saw a change of -11.16% in year-to-date performance and have moved -0.28% in past 5-day. Colgate-Palmolive Co (NYSE:CL) showed a performance of -4.86% in past 30-days. Number of shares sold short was 11.82 million shares which calculate 2.43 days to cover the short interests.
Wall Street analysts have assigned a consensus price target of 89 to the stock, which implies a rise of 1.19% to its recent value today. Analysts have been projecting 89 as a low price target for the stock while placing it at a high target of 89. It follows that stock’s current price would drop -1.21% in reaching the projected high whereas dropping to the targeted low would mean a loss of -1.21% for stock’s current value.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of 5.01% during past 5 years. In 2025, company’s earnings growth rate is likely to be around 1.64% while estimates for its earnings growth in next 5 years are of 5.60%.
CL Dividends
Colgate-Palmolive Co is more likely to be releasing its next quarterly report on 2025-Apr-25 and investors are confident in the company announcing better current-quarter dividends despite the fact that it has been facing issues arising out of mounting debt. With an annual yield of 2.30%, the share has a forward dividend of 2.02 which implies that company’s dividend yield remained growing in trailing twelve months while having a 5 year average dividend yield of 2.28%.
Colgate-Palmolive Co (NYSE:CL)’s Major holders
Insiders are in possession of 0.16% of company’s total shares while institution are holding 86.29 percent of that, with stock having share float percentage of 86.43%. Investors also watch the number of corporate investors in a company very closely, which is 86.29% institutions for Colgate-Palmolive Co that are currently holding shares of the company. VANGUARD GROUP INC is the top institutional holder at CL for having 80.32 million shares of worth $7.79 billion. And as of 2024-06-30, it was holding 9.7983 of the company’s outstanding shares.
The second largest institutional holder is BLACKROCK INC., which was holding about 61.62 million shares on 2024-06-30. The number of shares represents firm’s hold over 7.517 of outstanding shares, having a total worth of $5.98 billion.
On the other hand, VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund and VANGUARD INDEX FUNDS-Vanguard 500 Index Fund are the top two Mutual Funds which own company’s shares. As of Mar 31, 2025 , the former fund manager was holding 25.63 shares of worth $2.25 billion or 3.16% of the total outstanding shares. The later fund manager was in possession of 22.55 shares on Mar 31, 2025 , making its stake of worth around $1.98 billion in the company or a holder of 2.78% of company’s stock.
